Protection from PD with moderate Vitamin E intake Clinical trials also show no neuroprotective benefit of taking vitamin E A (Cansev et al., 2008) This combination increased levels of neural phosphatides, proteins in synaptic membranes, and dendritic spines in rodents DHA and uridine administration also reduced parkinsonian related behaviors and elevated DA levels in 6-OHDA rats A (Pileblad et al., 1989; Seaton et al., 1996; Wullner et al., 1996) Excessive or reduced GSH levels initiated degeneration of DA neurons Decreased GSH increased neuron susceptibility to neurotoxins, but did not correlate to DA viability or striatal terminals Depletion of DA was seen after MPTP treatment in GSH peroxidase-deficient mice Low levels of GSH reduced DA neurons after toxin administration 
NSAID (ibuprofen+ aspirin)
A/C (Bilodeau et al., 1995; Kaufmann et al., 1997; Aubin et al., 1998; Saini et al., 1998; Casper et al., 2000; Sairam et al., 2003) A/C (Esposito et al., 2007) A (Casper et al., 2000; Morioka et al., 2004; Carrasco et al., 2005) NSAID's protected against neuronal death and dopaminergic neurotoxicity NSAIDS showed neuroprotection in MPTP, 6-OHDA, and in vitro
Ibuprofen protected DA neurons against glutamate toxicity and decreased MPTP toxicity E (Chen et al., 2003; Ton et al., 2006; Wahner et al., 2007; Gao et al., 2011 ) E (Chen et al., 2005 Ton et al., 2006; Driver et al. 2011 , Gao et al., 2011 
